Skip to content
lifestyle.gooddecisions.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Galecto, Inc.
Galecto Announces Name Change to Damora Therapeutics with Mission to Fundamentally Redefine Care for Patients with Blood Disorders
March 9, 2026
Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference
March 2, 2026
Galecto Announces Pricing of $275 Million Underwritten Public Offering
February 13, 2026